A simple vaccine may soon be available to protect against urinary tract infections, thanks to researchers from University of Michigan.
The study conducted over mice showed that the vaccine prevented infection and produced key types of immunity.
Urinary Tract Infection in the paediatric patient - Introduction
Urinary Tract Infection in the paediatric patient
Advertisement
It alerts the immune system to iron receptors on the surface of Escherichia coli bacteria that perform a critical function allowing infection to spread.
Administered in the nose, it induces an immune response in the body's mucosa, a first line of defense against invading pathogens. The response, also produced in mucosal tissue in the urinary tract, should help the body fight infection where it starts.
![Anatomy of Urinary System - Animation]( "Anatomy of Urinary System - Animation")
Animation & slides showing anatomy of urinary system and the role of kidneys in getting rid of the waste products and excess fluid from our body to keep us healthy.
The researchers used novel systematic approach, combining bioinformatics, genomics and proteomics, to look for key parts of the bacterium that could be used in a vaccine to elicit an effective immune response.
The team, led by Dr. Harry L.T. Mobley, screened 5,379 possible bacterial proteins and identified three strong candidates to use in a vaccine to prime the body to fight E. coli.
Mobley's team is currently testing more strains of E. coli obtained from women treated at U-M.
If the robust immunity achieved in mice can be reproduced in humans, it could be the first ever vaccine for urinary tract infections.
Most of the strains produce the same iron-related proteins that can be vaccine targets, an encouraging sign that the vaccine could work against many urinary tract infections.
The findings are published in the open-access journal PLoS Pathogens.
Source: ANI
SRM
Anatomy of Urinary System - Animation
Animation & slides showing anatomy of urinary system and the role of kidneys in getting rid of the waste products and excess fluid from our body to keep us healthy.
Advertisement
The researchers used novel systematic approach, combining bioinformatics, genomics and proteomics, to look for key parts of the bacterium that could be used in a vaccine to elicit an effective immune response.
The team, led by Dr. Harry L.T. Mobley, screened 5,379 possible bacterial proteins and identified three strong candidates to use in a vaccine to prime the body to fight E. coli.
Mobley's team is currently testing more strains of E. coli obtained from women treated at U-M.
If the robust immunity achieved in mice can be reproduced in humans, it could be the first ever vaccine for urinary tract infections.
Most of the strains produce the same iron-related proteins that can be vaccine targets, an encouraging sign that the vaccine could work against many urinary tract infections.
The findings are published in the open-access journal PLoS Pathogens.
Source: ANI
SRM
Chest Or Urinary Tract Infection Could Double Memory Loss In Alzheimer’s Patients
Chest or urinary tract infection could double memory loss in Alzheimer's patients, say UK researchers.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.